Oral mucositis

CTCAE V5.0

Moderate pain or ulcer that does not interfer with oral intake; modified diet indicated

SIMPLIFIED GRADING

Moderate pain (VAS <6)

Possible ulcerations

Not interfering with oral intake. Modified diet indicated

References

Peuvrel L, Cassecuel J, Bernier C, Quéreux G, Saint-Jean M, Le Moigne M, Frénard C, Khammari A, Dréno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments. TOXICAN: a guide for grading dermatological adverse events of cancer treatments. Support Care Cancer. 2018;26:2871-7.

CTCAE V5.0

Severe pain; interfering with oral intake

SIMPLIFIED GRADING

Severe pain (VAS ≥ 6)

Widespread ulcerations

Interfering with oral intake

References

Peuvrel L, Cassecuel J, Bernier C, Quéreux G, Saint-Jean M, Le Moigne M, Frénard C, Khammari A, Dréno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments. TOXICAN: a guide for grading dermatological adverse events of cancer treatments. Support Care Cancer. 2018;26:2871-7.

CTCAE V5.0

Life-threatening consequences; urgent intervention indicated

SIMPLIFIED GRADING

Life-threatening consequences relating to impact on nutrition and hydration

References

Peuvrel L, Cassecuel J, Bernier C, Quéreux G, Saint-Jean M, Le Moigne M, Frénard C, Khammari A, Dréno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments. TOXICAN: a guide for grading dermatological adverse events of cancer treatments. Support Care Cancer. 2018;26:2871-7.